Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Risk of stroke lower with potent P2Y12 inhibitors vs clopidogrel in Chinese ACS patients
A retrospective study of over 6,000 Chinese patients with acute coronary syndrome (ACS) who underwent first-ever percutaneous coronary intervention (PCI) has shown that use of potent P2Y12 inhibitors, such as ticagrelor and prasugrel, is associated with lower risk of stroke than clopidogrel.
Risk of stroke lower with potent P2Y12 inhibitors vs clopidogrel in Chinese ACS patients
08 Apr 2022
Moderate fish consumption lowers all-cause, CVD mortality risks
Eating fish from four to six servings a week (29‒43 g/day) appears to reduce the risks of all-cause and cardiovascular disease (CVD) mortality, results of a China study have shown.
Moderate fish consumption lowers all-cause, CVD mortality risks
07 Apr 2022
High-intensity statins help lower cholesterol among diabetics
Treatment with rosuvastatin, given at moderate and high intensity doses, as well as simvastatin and atorvastatin, given at high intensity doses, modestly reduce levels of nonhigh-density lipoprotein cholesterol (non-HDL-C) in diabetic patients over 12 weeks compared with placebo, a study has shown.
High-intensity statins help lower cholesterol among diabetics
05 Apr 2022
Resistance exercise could improve sleep duration, efficiency
Individuals at elevated cardiovascular disease risk (overweight/obese, increased blood pressure levels) may improve the duration and efficiency of their sleep through regular resistance exercise regimens, according to a study presented at the EPI Lifestyle Scientific Sessions 2022.
Resistance exercise could improve sleep duration, efficiency
04 Apr 2022
Allo-HSCT recipients at higher risk of metabolic diseases
Rigorous monitoring is necessary among recipients of allogeneic haematopoietic stem cell transplantation (allo-HSCT) for the development of metabolic diseases, such as hypertension, diabetes, dyslipidaemia, and cardiovascular disease (CVD), suggests a recent study.